Endogenous nitric oxide in allergic airway disease

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 3, 2000, Pages 438-448

  Silkoff, Philip E ^a   Robbins, Richard A ^b   Gaston, Benjamin ^c   Lundberg, Jon O N ^d   Townley, Robert G ^e  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e CREIGHTON UNIVERSITY   (United States)

Author keywords

Asthma; Nasal; Nitric oxide; Rhinitis

Indexed keywords

NITRIC OXIDE;

ASTHMA; BRONCHUS HYPERREACTIVITY; DISEASE MARKER; HUMAN; IMMUNE SYSTEM; INFLAMMATION; NOSE DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0034111266     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.104938     Document Type: Article

References (100)

1. 1. Gustaffson LE, Leone AM, Persson MG, et al. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991;181:852-7.
2. 2. Lundberg JO, Weitzberg E, Nordvall SL, et al. Primarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome. Eur Respir J 1994;7:1501.
3. 3. Silkoff PE, McClean P, Slutsky AS, et al. Exhaled nitric oxide and bronchial reactivity during and after inhaled beclomethasone in mild asthma. J Asthma 1998;35:473.
4. 4. Geller DA, Billiar TR. Molecular biology of nitric oxide synthases. Cancer Metastasis Rev 1998;17:7.
5. 5. Asano K, Chee CB, Gaston B, et al. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci U S A 1994;91:10089.
6. 6. Gaston B, Kobzik L, Stamler JS. Distribution of nitric oxide synthase in the lung. In: Zapol W, Bloch K, editors. Nitric oxide and the lung. New York: Marcel Dekker; 1997. p 75-86.
7. 7. Kobzik L, Bredt DS, Lowenstein CJ, et al. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol 1993;9:371.
8. 8. Xue C, Botkin SJ, Johns RA. Localization of endothelial NOS at the basal microtubule membrane in ciliated epithelium of rat lung. J Histochem Cytochem 1996;44:463.
9. 9. Yates DH, Kharitonov SA, Thomas PS, et al. Endogenous nitric oxide is decreased in asthmatic patients by an inhibitor of inducible nitric oxide synthase. Am J Respir Crit Care Med 1996;154:247.
10. 10. De Sanctis GT, MacLean JA, Hamada K, et al. Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma. J Exp Med 1999;189:1621.
11. 11. Gaston B, Reilly J, Drazen JM, et al. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci U S A 1993;90:10957.
12. 12. Haddad IY, Pataki G, Hu P, et al. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest 1994;94:2407.
13. 13. Hunt J, Byrns RE, Ignarro LJ, et al. Condensed expirate nitrite as a home marker for acute asthma [letter]. Lancet 1995;346:1235.
14. 14. Gaston B, Stamler JS. Nitric oxides and lung function. In: Crystal R, West J, Weibel E, Barnes P, editors. The lung: scientific foundations. Philadelphia: Lippincott-Raven; 1997. p 239-53.
15. 15. De Groote MA, Testerman T, Xu Y, et al. Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium. Science 1996;19:272:414.
16. 16. Mannick JB, Hausladen A, Liu L, et al. Fas-induced caspase denitrosylation. Science 1999;284:651.
17. 17. Saura M, Zaragoza C, McMillan A, et al. An antiviral mechanism of nitric oxide: inhibition of a viral protease. Immunity 1999;10:21.
18. 18. Soderman C, Leone A, Furst V, et al. Endogenous nitric oxide in exhaled air from patients with liver cirrhosis. Scand J Gastroenterol 1997;32:591.
19. 19. Mian KB, Martin W. The inhibitory effect of 3-amino-1,2,4-triazole on relaxation induced by hydroxylamine and sodium azide but not hydrogen peroxide or glyceryl trinitrate in rat aorta. Br J Pharmacol 1995;116:3302.
20. 20. Schmidt HH, Hofmann H, Schindler U, et al. NO from NO synthase. Proc Natl Acad Sci U S A 1996;93:14492.
21. 21. Jones KL, Bryan TW, Jinkins PA, et al. Superoxide released from neutrophils causes a reduction in nitric oxide gas. Am J Physiol 1998;275:L1120.
22. 22. Hunt J, Fang K, Platts-Mills TAE, et al. Nitrogen oxide redox balance in asthma [abstract]. Am J Respir Crit Care Med 1999;159:A860.
23. 23. Gaston B, Sears S, Woods J, et al. Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure. Lancet 1998;351:1317.
24. 24. Gaston B. Nitric oxide and thiol groups. Biochim Biophys Acta 1999;1411:1317.
25. 25. Gaston B, Canady R, Hunt J, et al. High ammonia and low nitric oxide levels in the cystic fibrosis airway: adverse effects of Pseudomonas? [abstract] Am J Respir Crit Care Med 1999;159:A306.
26. 26. Kanazawa H, Shoji S, Yamada M, et al. Increased levels of nitric oxide derivatives in induced sputum in patients with asthma. J Allergy Clin Immunol 1997;99:624-9.
27. 27. Robbins RA, Boggs PJ, Simpson KL, et al. Endobronchial challenge is associated with increased lower respiratory tract nitric oxide [abstract]. Am J Respir Crit Care Med 1999;159:A862.
28. 28. Sato M, Fukuyama N, Sakai M, et al. Increased nitric oxide in nasal lavage fluid and nitrotyrosine formation in nasal mucosa - indices for severe perennial nasal allergy. Clin Exp Allergy 1998;28:597.
29. 29. Ischiropoulos H, Zhu L, Chen J, et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 1992;298:431.
30. 30. Haddad IY, Crow JP, Hu P, et al. Concurrent generation of nitric oxide and superoxide damages surfactant protein A. Am J Physiol 1994;267:L242.
31. 31. Kharitonov SA, Yates D, Robbins RA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994;343:133.
32. 32. Balough K, McCubbin M, Weinberger M, et al. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol 1995;20:63.
33. 33. Greally P, Hussein MJ, Cook AJ, et al. Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosis. Arch Dis Child 1993;68:389.
34. 34. Dotsch J, Demirakea S, Terbrack HG, et al. Airway nitric oxide in asthmatic children and patients with cystic fibrosis. Eur Respir J 1996:9:2537.
35. 35. Lundberg JO, Nordvall SL, Weitzberg E, et al. Exhaled nitric oxide in paediatric asthma and cystic fibrosis. Arch Dis Child 1996;75:323.
36. 36. Jones KL, Hegab AH, Hillman BC. Elevation of nitrate and nitrotyrosine in cystic fibrosis sputum. Pediatr Pulmonol 1999. In press.
37. 37. Sato E, Simpson KL, Grisham MB, et al. Effects of reactive oxygen and nitrogen metabolites on RANTES and IL-5 induced eosinophil chemotactic activity in vitro. Am J Pathol 1999;155:591.
38. 38. Hamid Q, Springall DR, Riveros-Moreno V, et al. Induction of nitric oxide synthase in asthma. Lancet 1993;342:1510.
39. 39. Robbins RA, Sisson JH, Springall DR, et al. Human lung mononuclear cells induce nitric oxide synthase in murine airway epithelial cells in vitro: role of TNFalpha and IL-1beta. Am J Respir Crit Care Med 1997;155:268.
40. 40. Guo FH, Uetani K, Haque SJ, et al. Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators [published erratum appears in J Clin Invest 1997;100:1322]. J Clin Invest 1997;100:829.
41. 41. Kharitonov SA, O'Connor BJ, Evans DJ, et al. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med 1995;151:1894.
42. 42. Jatakanon A, Lim S, Kharitonov SA, et al. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998;53:91.
43. 43. Belenky SN, Robbins RA, Rennard SI, et al. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro. J Lab Clin Med 1993;122:388.
44. 44. Belenky SN, Robbins RA, Rubinstein I. Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro. J Leukoc Biol 1993;53:498.
45. 45. Robbins RA, Romero FA, Nelson KJ, et al. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro [abstract]. Am J Respir Crit Care Med 1995;151:A238.
46. 46. Townley RG, Romero FA, Robbins RA. The effect of nitric oxide synthase on the early and late allergic skin response. J Allergy Clin Immunol 1995;95:358.
47. 47. Barnes PJ, Liew FY. Nitric oxide and asthmatic inflammation. Immunol Today 1995;16:128.
48. 48. Taylor-Robinson AW, Philipos RS, Severin A, et al. The role of Th1 and Th2 cells in a rodent malaria infection. Science 1993;260:1931.
49. 49. Feder LS, Stelts D, Chapman RW, et al. Role of nitric oxide on eosinophilic lung inflammation in allergic mice. Am J Respir Cell Mol Biol 1997;17:436.
50. 50. Radi R, Beckman JS, Bush KM, et al. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991;288:481.
51. 51. Saleh D, Ernst P, Lim S, et al. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J 1998;12:929.
52. 52. Kanazawa H, Satoshi S, Okamoto T, et al. Inhibition of bronchoprotective efects of beta-2 adrenoceptor agonists by peroxynitrite in guinea pig airways. Am J Respir Crit Care Med 1999;159:1272.
53. 53. Kharitonov SA, Yates D, Barnes PJ. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur Respir J 1995;8:295.
54. 54. Silkoff PE, Caramori M, Tremblay L, et al. Exhaled nitric oxide in human lung transplantation: a noninvasive marker of acute rejection. Am J Respir Crit Care Med 1998;157:1822.
55. 55. Rolla G, Brussino L, Bertero MT, et al. Increased nitric oxide in exhaled air of patients with systemic lupus erythematosus. J Rheumatol 1997;24:1066.
56. 56. Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996;153:454.
57. 57. Kharitonov SA, Yates DH, Chung KF, et al. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J 1996;9:196.
58. 58. Robbins RA, Sisson JH. Nitric oxide. In: Townley RG, Agrawal DK, editors. Immunopharmacology of allergic diseases. New York: Marcel Dekker; 1996.
59. 59. Kharitonov SA, Yates D, Springall DR, et al. Exhaled nitric oxide is increased in asthma. Chest 1995;107:156S.
60. 60. Massaro AF, Gaston B, Kita D, et al. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 1995;152:800.
61. 61. Chatkin JM, Ansarin K, Silkoff PE, et al. Exhaled nitric oxide as a noninvasive assessment of chronic cough. Am J Respir Crit Care Med 1999;159:1810.
62. 62. Sont JK, Willems LN, Bel EH, et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment: the AMPUL Study Group. Am J Respir Crit Care Med 1999;159:1043.
63. 63. Dupont LJ, Rochette F, Demedts MG, et al. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma. Am J Respir Crit Care Med 1998;157:894.
64. 64. Jatakanon A, Kharitonov S, Lim S, et al. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax 1999;54:108.
65. 65. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993;6:1368.
66. 66. Gerlach H, Rossaint R, Pappert D, et al. Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx. Lancet 1994;343:518.
67. 67. Lundberg JO, Farkas-Szallasi T, Weitzberg E, et al. High nitric oxide production in human paranasal sinuses. Nat Med 1995;1:370.
68. 68. Geller DA, Lowenstein CJ, Shapiro RA, et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci U S A 1993;90:3491.
69. 69. Lundberg JO, Weitzberg E, Rinder J, et al. Calcium-independent and steroid-resistant nitric oxide synthase activity in human paranasal sinus mucosa. Eur Respir J 1996;9:1344.
70. 70. Ramis I, Lorente J, Rosello-Catafau J, et al. Differential activity of nitric oxide synthase in human nasal mucosa and polyps. Eur Respir J 1996;9:202.
71. 71. Schedin U, Norman M, Gustafsson LE, et al. Endogenous nitric oxide in the upper airways of healthy newborn infants. Pediatr Res 1996;40:148.
72. 72. Lundberg JO, Rinder J, Weitzberg F, et al. Heavy physical exercise decreases nitric oxide levels in the nasal airways in humans. Acta Physiol Scand 1997;159:51.
73. 73. Baraldi E, Azzolin NM, Biban P, et al. Effect of antibiotic therapy on nasal nitric oxide concentration in children with acute sinusitis. Am J Respir Crit Care Med 1997;155:1680.
74. 74. Kharitonov SA, Rajakulasingam K, O'Connor B, et al. Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. J Allergy Clin Immunol 1997;99:58.
75. 75. Martin U, Bryden K, Devoy M, et al. Increased levels of exhaled nitric oxide during nasal and oral breathing in subjects with seasonal rhinitis. J Allergy Clin Immunol 1996;97:768.
76. 76. Rinder J, Lundberg JON, Anggard A, et al. Effects of topical nasal decongestants, L-arginine and nitric oxide synthase inhibition on nasal cavity nitric oxide levels and nasal cavity volume in man. Am J Rhinol 1996;10:399.
77. 77. Albert J, Schedin U, Lindqvist M, et al. Blockade of endogenous nitric oxide production results in moderate hypertension, reducing sympathetic activity and shortening bleeding time in healthy volunteers. Acta Anaesthesiol Scand 1997;41:1104.
78. 78. Mancinelli RL, McKay CP. Effects of nitric oxide and nitrogen dioxide on bacterial growth. Appl Environ Microbiol 1983;46:198.
79. 79. Lundberg JO. Airborne nitric oxide: inflammatory marker and aerocrine messenger in man. Acta Physiol Scand Suppl 1996;633:1.
80. 80. Runer T, Cervin A, Lindberg S, et al. Nitric oxide is a regulator of mucociliary activity in the upper respiratory tract. Otolaryngol Head Neck Surg 1998;119:278.
81. 81. Lundberg JON, Hellstrom PM, Lundberg JM, et al. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 1994;344:1673.
82. 82. Lundberg JO, Ehren I, Jansson O, et al. Elevated nitric oxide in the urinary bladder in infectious and noninfectious cystitis. Urology 1996;48:700.
83. 83. Beckman JS, Beckman TW, Chen J, et al. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990;87:1620.
84. 84. McCafferty DM, Mudgett JS, Swain MG, et al. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology 1997;112:1022.
85. 85. Puybasset L, Rouby JJ, Mourgeon E, et al. Inhaled nitric oxide in acute respiratory failure: dose-response curves. Intensive Care Med 1994;20:319.
86. 86. Lundberg JO, Lundberg JM, Settergren G, et al. Nitric oxide, produced in the upper airways, may act in an 'aerocrine' fashion to enhance pulmonary oxygen uptake in humans. Acta Physiol Scand 1995;155:467.
87. 87. Kharitonov S, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations: the European Respiratory Society Task Force. Eur Respir J 1997;10:1683.
88. 88. Silkoff P/E, Drazen JM, Gaston B, et al. American Thoracic Society/American Lung Association: recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. Am J Respir Crit Care Med 1999. In press.
89. 89. Dweik RA, Laskowski D, Abu-Soud HM, et al. Nitric oxide synthesis in the lung: regulation by oxygen through a kinetic mechanism J Clin Invest 1998;101:660.
90. 90. Silkoff PE, McClean P, Caramori M, et al. A significant proportion of exhaled nitric oxide arises in large airways in normal subjects. Respir Physiol 1998;113:33.
91. 91. Silkoff PE, McClean PA, Slutsky AS, et al. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med 1997;155:260.
92. 92. Silkoff PE, Stevens A, Pak J, et al. A method for the standardized offline collection of exhaled nitric oxide. Chest 1999;116:754.
93. 93. Canady RG, Platts-Mills T, Murphy A, et al. Vital capacity reservoir and online measurement of childhood nitrosopnea are linearly related: clinical implications. Am J Respir Crit Care Med 1999;159:311.
94. 94. Baraldi E, Dario C, Ongaro R, et al. Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children. Am J Respir Crit Care Med 1999;159:1284.
95. 95. Silkoff PE, Chatkin J, Qian W, et al. Nasal nitric oxide: a comparison of measurement techniques. Am J Rhinol 1999;13:169.
96. 96. Franklin PJ, Taplin R, Stick SM. A community study of exhaled nitric oxide in healthy children. Am J Respir Crit Care Med 1999;159:69.
97. 97. Silkoff PE, Chatkin J, McClean P, et al. Exhaled nitric oxide after beta-2 agonist inhalation and spirometry in bronchial asthma. Am J Respir Crit Care Med 1999;159:940.
98. 98. de Gouw HWFM, Hendriks J, Woltman AM, et al. Exhaled nitric oxide (NO) is reduced shortly after bronchoconstriction to direct and indirect stimuli in asthma. Am J Respir Crit Care Med 1998;158:315.
99. 99. Zetterquist W, Pedroletti C, Lundberg JO, et al. Salivary contribution to exhaled nitric oxide. Eur Respir J 1999;13:327.
100. 100. Kharitonov SA, Robbins RA, Yates D, et al. Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med 1995;152:609.